Securinine, a myeloid differentiation agent with therapeutic potential for AML.
Securinine, a myeloid differentiation agent with therapeutic potential for AML.
复制标题
DOI:
10.1371/journal.pone.0021203
复制
发表时间:
2011
期刊:
影响因子:
3.7
通讯作者:
Wald DN
中科院分区:
文献类型:
--
作者:
Gupta K;Chakrabarti A;Rana S;Ramdeo R;Roth BL;Agarwal ML;Tse W;Agarwal MK;Wald DN
As the defining feature of Acute Myeloid Leukemia (AML) is a maturation arrest, a highly desirable therapeutic strategy is to induce leukemic cell maturation. This therapeutic strategy has the potential of avoiding the significant side effects that occur with the traditional AML therapeutics. We identified a natural compound securinine, as a leukemia differentiation-inducing agent. Securinine is a plant-derived alkaloid that has previously been used clinically as a therapeutic for primarily neurological related diseases. Securinine induces monocytic differentiation of a wide range of myeloid leukemia cell lines as well as primary leukemic patient samples. Securinine's clinical potential for AML can be seen from its ability to induce significant growth arrest in cell lines and patient samples as well as its activity in significantly impairing the growth of AML tumors in nude mice. In addition, securinine can synergize with currently employed agents such as ATRA and decitabine to induce differentiation. This study has revealed securinine induces differentiation through the activation of DNA damage signaling. Securinine is a promising new monocytic differentiation inducing agent for AML that has seen previous clinical use for non-related disorders.
登录
查看更多内容
影响因子:
6.4
作者:
COLLINS, SJ;BODNER, A;GALLO, RC
通讯作者:
GALLO, RC
影响因子:
11.4
作者:
Asada, M;Yamada, T;Mizutani, S
通讯作者:
Mizutani, S
影响因子:
3.7
作者:
Meyer M;Rübsamen D;Slany R;Illmer T;Stabla K;Roth P;Stiewe T;Eilers M;Neubauer A
通讯作者:
Neubauer A
影响因子:
11.2
作者:
Wald, David N.;Vermaat, Hanna M.;Tse, William
通讯作者:
Tse, William
影响因子:
4.8
作者:
Rana, Sonia;Gupta, Kalpana;Wald, David N.
通讯作者:
Wald, David N.